Y-Intercept (HK)’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.8M Sell
573,581
-501,841
-47% -$4.57M 0.1% 289
2026
Q1
$9.69M Buy
1,075,422
+1,008,548
+1,508% +$15.9M 0.18% 115
2025
Q4
$1.22M Sell
66,874
-38,409
-36% -$647K 0.03% 886
2025
Q3
$1.54M Buy
105,283
+30,392
+41% +$521K 0.04% 764
2025
Q2
$1.36M Buy
74,891
+38,809
+108% +$791K 0.03% 786
2025
Q1
$716K Buy
36,082
+6,333
+21% +$110K 0.05% 544
2024
Q4
$510K Buy
+29,749
New +$560K 0.03% 714
2024
Q3
Sell
-34,055
Closed -$381K 1249
2024
Q2
$381K Buy
+34,055
New +$286K 0.02% 935
2023
Q3
Sell
-19,204
Closed -$70.9K 1008
2023
Q2
$70.9K Buy
+19,204
New +$71.2K 0.01% 1164
2022
Q2
Sell
-48,328
Closed -$88K 831
2022
Q1
$88K Buy
+48,328
New +$75.4K 0.02% 680
2021
Q3
Sell
-16,656
Closed -$27K 620
2021
Q2
$27K Buy
+16,656
New +$29.3K 0.01% 576

Other funds holding ADMA